glp-1 news today 2025 november 5 Opinion | Experimentation Is Everywhere, and Science Can't Keep Up GLP-1 Weight Loss Drug Enforcement
Description
The OASIS 4 trial demonstrated 13.6% mean body weight loss at 64 weeks with oral semaglutide 25 mgcomparable to injectable formulations
But these results came from consistent, properly dosed weekly injections over many months
Appetite Suppression Duration: Weekly injections provide continuous appetite reduction
National Institute on Deafness and Other Communication Disorders
For the vast majority of people, the answer is yes, you can donate plasma while taking a GLP-1 medication for weight loss
Speak with your healthcare provider
